Here you can find all scientific publications about LAKANA and its´ substudies

• Adubra L, Alber D, Ashorn P, Ashorn U, Cheung YB, Cloutman-Green E, Diallo F, Ducker C, Elovainio R, Fan YM, Gates L, Gruffudd G, Haapaniemi T, Haidara F, Hallamaa L, Ihamuotila R, Klein N, Luoma J, Martell O, Sow S, Vehmasto T and LAKANA Trial team 2023. Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11 -month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, paraller-group, three-arm clinical trial. Trials (2023) 24:5 [LAKANA main study]

• Alber D, Haidara FD, Luoma J, Adubra L, Ashorn P, Ashorn U, Badji H, Cloutman-Green E, Diallo F, Ihamuotila R, Klein N, Martell O, Onwuckhekwa U, Oumar S, Sow S, Traore A, Wilson K, Ducker C and Fan YM. 2022. SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020–2021. BMJ Open 2022. [LAKANA-COVID substudy]